Entero Healthcare Solutions

1,322.60
-18.60
(-1.39%)
Market Cap
5,754.33 Cr
EPS
10.81
PE Ratio
64.74
Dividend Yield
0.00 %
Industry
Retail
52 Week High
1,584.25
52 Week Low
991.10
PB Ratio
3.47
Debt to Equity
0.35
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
793.10
#1 9,492.92
74.14
#1 5,664.90
#1 23.05
#1 66
235.04
57.36
1,322.60
#2 5,754.33
#1 64.74
#2 3,936.70
#2 19.09
#2 40
#1 321.43
59.67
Growth Rate
Revenue Growth
19.09 %
Net Income Growth
-458.56 %
Cash Flow Change
19.22 %
ROE
-230.11 %
ROCE
-12.10 %
EBITDA Margin (Avg.)
52.86 %

Quarterly Financial Results

Quarterly Financials
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
832
888
901
998
994
1,043
1,111
1,312
1,367
Expenses
810
867
873
968
964
1,005
1,067
1,258
1,309
EBITDA
21
21
27
31
30
38
44
54
58
Operating Profit %
2 %
2 %
3 %
3 %
3 %
3 %
3 %
3 %
4 %
Depreciation
5
7
6
6
6
7
7
8
8
Interest
13
13
14
18
16
17
10
12
10
Profit Before Tax
3
1
7
7
8
14
27
35
39
Tax
-1
5
0
2
1
-8
7
9
10
Net Profit
4
-4
6
5
7
21
21
26
30
EPS in ₹
8.67
1.49
15.18
3.24
4.21
5.73
4.62
5.43
5.85

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
Total Assets
749
836
1,126
1,309
2,345
Fixed Assets
186
189
262
268
289
Current Assets
552
636
851
1,023
2,011
Capital Work in Progress
2
2
1
0
0
Investments
0
0
0
0
0
Other Assets
561
645
863
1,041
2,056
Total Liabilities
749
836
1,126
1,309
2,345
Current Liabilities
269
291
462
624
602
Non Current Liabilities
56
58
101
87
102
Total Equity
424
487
563
598
1,641
Reserve & Surplus
-16
-32
-62
-73
1,593
Share Capital
439
517
4
4
44

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
-23
-11
14
-21
122
Investing Activities
-203
-31
-162
-49
-704
Operating Activities
-37
-69
-35
-45
-37
Financing Activities
217
89
211
73
863

Share Holding

% Holding
Sept 2023
Feb 2024
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
78.85 %
52.44 %
52.44 %
52.44 %
52.44 %
52.44 %
52.42 %
FIIs
0.00 %
0.00 %
23.30 %
23.32 %
23.82 %
22.21 %
19.92 %
DIIs
0.00 %
1.36 %
2.28 %
2.06 %
7.73 %
8.77 %
9.64 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
5.72 %
4.95 %
5.00 %
4.06 %
4.36 %
5.41 %
Others
21.15 %
40.48 %
17.03 %
17.18 %
11.95 %
12.23 %
12.61 %
No of Share Holders
51
58
80,864
66,400
36,767
33,172
33,159

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 28, 2025
Closure of Trading WindowMar 24, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 21, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On March 21 2025Mar 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 19, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 20, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 19, 2025
Intimation Of Cancellation Of Analyst/ Institutional Investor Meeting Scheduled On February 21 2025Feb 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 12, 2025
Statement Of Deviation For The Quarter Ended December 31 2024Feb 12, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 12, 2025
Integrated Filing (Financial)Feb 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On February 12 2025Feb 12, 2025
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 08, 2025
Board Meeting Intimation for Approval And Take On Record The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2024.Feb 03, 2025
Intimation Regarding Receipt Of Listing And Trading Approval For 13940 Equity Shares From The BSE Limited (BSE) And National Stock Exchange Of India Limited (NSE)Jan 31, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 25, 2025
Disclosure under Regulation 30A of LODRJan 16, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 16, 2025
Appointment of Company Secretary and Compliance OfficerJan 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 10, 2025
Change Of Name Of Registrar And Share Transfer Agent ("RTA") Of The CompanyJan 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 02, 2025
Closure of Trading WindowDec 23, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 10, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerDec 09, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 19, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 13, 2024
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 13, 2024
Statement Of Deviation Or Variation For The Quarter Ended September 30, 2024Nov 13, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationNov 13, 2024
Announcement under Regulation 30 (LODR)-AcquisitionNov 12, 2024
Announcement under Regulation 30 (LODR)-AcquisitionNov 12, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On November 12, 2024Nov 12, 2024
Results- Financial Results For September 30, 2024Nov 12, 2024

Technical Indicators

RSI(14)
Neutral
59.67
ATR(14)
Less Volatile
62.28
STOCH(9,6)
Neutral
77.27
STOCH RSI(14)
Neutral
76.13
MACD(12,26)
Bullish
20.36
ADX(14)
Strong Trend
28.74
UO(9)
Bearish
52.69
ROC(12)
Uptrend And Accelerating
11.14
WillR(14)
Neutral
-29.68